Wayland Group Corp. (CSE:WAYL; FWB:75M; OTCQB:MRRCF) (“Wayland” or the “Company”) has reported its financial and operating results for the third quarter ended September 30, 2018 and has filed the full report on SEDAR.

“Consistent with previous guidance, we reserved product for European export and the recreational market in Canada, which legalized cannabis for adult use on October 17th. We have successfully delivered product in Q4 to Alberta, British Columbia, Manitoba and Ontario after initial sampler packs in one-gram format were delivered prior to legalization, allowing consumers the ability to try a broader assortment of strains and familiarize themselves with cannabis. Our Kiwi, Northern Harvest and High Tide products have received positive acclaim. We continue to await regulatory approval in Canada for the remainder of our expansion, which will provide the Company with greater supply capabilities.” Stated Ben Ward, CEO of Wayland Group.

Highlights for the quarter include:

  • Entered into supply agreements to provide cannabis to BC Liquor and Ontario’s OCS and delivered product.
  • Directly received letter of intent for license approval from the Government of Malta.
  • Closed a Private Placement raising gross proceeds of $37.4 million during the reporting period.
  • Launched First Cannabidiol (CBD) formulation utilizing patented drug delivery technology in a soft gel formulation loaded with 25mg of CBD per capsule that utilizes the multi-patented VESIsorb® delivery system to ensure optimum absorption and bioavailability.
  • First high yielding harvest and the beginning of CBD production in Germany. Wayland’s European nutraceutical subsidiary MariPlant, commenced the harvest of approximately 165 hectares (~405 acres) of hemp, which resulted in 120,000 kg of extractable material.
  • Shipped first CBD capsules to German market and pharmacies.
  • Entered into Non-Binding joint venture in Italy with San Martino S.S. to expand global footprint, subsequently completed the definitive JV.
  • Launched recreational products for the Canadian market. Kiwi was designed to simplify cannabis for people new to the product.
  • Zurich was chosen as the location for Wayland’s first retail store.

All figures are stated in Canadian Dollars. At September 30, 2018, Wayland recognized revenue of $225,122 and $1,983,600 for the three and nine months ended September 30, 2018, respectively, as compared to $721,035 and $2,525,000 during the same periods in 2017. The decrease in revenues can be attributed to the Company shifting resources to address the recently legalized recreational adult-use market in Canada.
Additional details of the three and nine months ended financial results for fiscal years 2018 and 2017 under International Financial Reporting Standards (IFRS) are available at www.sedar.com or on the Company’s website.

Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.

About Wayland Group

Wayland is a vertically integrated cultivator and processor of cannabis. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany, Regensdorf, Switzerland and Ibague, Colombia. Wayland has also announced transactions that will expand its global footprint to include operations in Italy and the UK. Wayland will continue to pursue new opportunities globally in its effort to enhance lives through cannabis.

Forward Looking Information

This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein.  Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release

For more information about Wayland, please visit our website at www.waylandgroup.com

Contact Information:
Investor Relations
Graham Farrell
VP, Communications

Media Inquiries: media@waylandgroup.com

Corporate Headquarters (Canada)
Wayland Group Corp. (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3
European Headquarters (Germany)
Maricann GmbH
Thierschstrasse 3, 80538 Munchen, Deutschland

Click here to connect with Wayland Group Corp. (CSE:WAYL, FWB:75M, OTCQB:MRRCF) for an Investor Presentation.

Source: globenewswire.com

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less